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Background: Macrophage infiltration to inflammatory sites promotes wound repair and may be involved in pain
hypersensitivity after surgical incision. We recently reported that the development of hyperalgesia during chronic
inflammation is regulated by macrophage polarity, often referred to as proinflammatory (M1) or anti-inflammatory
(M2) macrophages. Although opioids such as morphine are known to alter the inflammatory milieu of incisional
wounds through interactions with immunocytes, the macrophage-mediated effects of morphine on the
development of postincisional pain have not been well investigated. In this study, we examined how morphine
alters pain hypersensitivity through phenotypic shifts in local macrophages during the course of incision-induced
inflammation.
Results: Local administration of morphine in the early phase, but not in the late phase alleviated mechanical
hyperalgesia, and this effect was reversed by clodronate-induced peripheral depletion of local macrophages. At
the morphine-injected incisional sites, the number of pro-inflammatory F4/80+iNOS+M1 macrophages was decreased
during the course of pain development whereas increased infiltration of wound healing F4/80+CD206+M2 macrophages
was observed during the early phase. Morphine increased the gene expression of endogenous opioid, proenkephalin,
and decreased the pronociceptive cytokine, interleukin-1β. Heme oxygenase (HO)-1 promotes the differentiation
of macrophages to the M2 phenotype. An inhibitor of HO-1, tin protoporphyrin reversed morphine-induced
analgesic effects and the changes in macrophage phenotype. However, local expression levels of HO-1 were not
altered by morphine. Conversely, cyclooxygenase (COX)-2, primarily produced from peripheral macrophages
in acute inflammation states, was up-regulated in the early phase at morphine-injected sites. In addition, the
analgesic effects and a phenotype switching of infiltrated macrophages by morphine was reversed by local
administration of a COX inhibitor, indomethacin.
Conclusions: Local administration of morphine alleviated the development of postincisional pain, possibly by
altering macrophage polarity at the incisional sites. A morphine-induced shift in macrophage phenotype may
be mediated by a COX-2-dependent mechanism. Therefore, μ-opioid receptor signaling in macrophages may
be a potential therapeutic target during the early phase of postincisional pain development.
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Peripheral neuroimmune interactions play an important
role in the development of pain hypersensitivity and in
the process of wound healing after surgery. Macro-
phages, predominately activated during the early stage of
the postoperative periods, eliminate necrotic tissue and
protect the wound from post-surgical infection by in-
creasing their phagocytic activity [1].
Macrophages can acquire distinct functional pheno-
types depending on their microenvironment, such as is
present at inflamed sites. Two well-established polarized
macrophage phenotypes are proinflammatory (M1) and
wound healing (M2) macrophages. M1 macrophages
produce high levels of toxic intermediates associated
with increased phagocytic activity and pro-nociceptive
mediators, such as inducible NO synthase (iNOS) and
cyclooxygenase (COX)-2 [2], whereas M2 macrophages
display homeostatic functions linked to wound heal-
ing [3]. Mice lacking CCR2, a marker for the M1
phenotype and a receptor for macrophage-specific
chemo-attractant macrophage chemoattractant protein-1,
showed impaired inflammatory pain development and
decreased macrophage infiltration to complete Freund’s ad-
juvant (CFA)-induced sites of inflammation [4], suggesting
that M1 macrophages exacerbate the development of
hyperalgesia after inflammation. The influx of M2 macro-
phages in the late phase is preceded by an influx of M1
macrophages [5]. The phenotypic shift in macrophages to-
ward an M2 phenotype is predominantly promoted by
heme oxygenase (HO)-1, a stress-responsive enzyme with
potent antioxidant and anti-inflammatory activities that
is induced immediately after incision and that has
antihyperalgesic effects against inflammatory pain after
formalin injection [6-8]. We recently demonstrated that the
activation of peroxisome proliferator-activated receptor
(PPAR)γ signaling promotes macrophage polarization to-
wards the M2 phenotype through an HO-1-dependent
pathway, attenuating the development of CFA-induced in-
flammatory pain [6]. In addition, PPARγ agonist alleviated
postincisonal pain by regulating macrophage phenotype [9].
Therefore, the balance between these two subsets of macro-
phages plays a crucial role in regulating the inflammation
and pain development processes.
Peripherally-applied morphine can attenuate inflam-
matory pain induced by carrageenan [10] and CFA
[11]. Morphine regulates the production of neuro-
transmitters involved in nociception, such as substance
P and iNOS, by phagocytes at inflamed sites [12,13].
Recently, the peripheral actions of opioids on immune
cells during the course of postoperative wound repair
have been suggested. It was reported that morphine
inhibited the monocyte-macrophage conversion phase,
resulting in delayed migration of monocytes at the sites
of injury [14]. Peripheral administration of morphinesuppressed the phagocytic activity of macrophages
and promoted apoptosis by an HO-1-dependent mech-
anism [15,16]. These data suggest that morphine might
regulate peripheral sensitization through local neuro-
inflammatory processes, particularly macrophages.
In closing wounds that were locally treated with mor-
phine sulfate, macrophage infiltration was decreased in
the early phase but increased in the late phase of the
wound healing process [17]. In addition, acute morphine
administration reduced peri-incisional expression of pro-
inflammatory cytokines such as interleukin (IL)-1β and
tumor necrosis factor (TNF)-α [18], which are major
nociceptive mediators produced by M1 macrophages
[19]. Therefore, these reports support our hypothesis
that morphine alters the M1/M2 balance in incised sites
during the postoperative period.
Although acute peripheral actions of morphine have
been suggested, the macrophage-mediated effects of
morphine on the development of postincisional pain
have not been well investigated. Therefore, we first
examined whether repeated administrations of mor-
phine to incised sites had analgesic effects, and then
evaluated whether the effects of morphine were medi-
ated by a shift in macrophage polarity at the incision
sites.Results and discussion
Local administration of morphine in the early phase of
postincisional pain development ameliorates mechanical
hyperalgesia
To evaluate the effects of locally administered mor-
phine on the development of postincisional hyperalge-
sia, morphine was injected into the incised sites daily
for 3 days during the early phase (an hour after the
procedure and then on postoperative days [POD] 1
and 2) or during the late phase (on PODs 5, 6, and 7).
Hyperalgesia to mechanical stimuli was attenuated on
PODs 7, 12, and 14 in mice that received morphine in
the early phase. This attenuation was reversed to the
level of vehicle-injected mice by coadministration of a
non-selective opioid receptor antagonist, naloxone
(Figure 1A, two-way analysis of variance (ANOVA): F
(4, 245) = 12.23, P < 0.0001). In contrast to the effects
of morphine on mechanical stimuli, morphine had
no effect on withdrawal latency to thermal stimuli
(Figure 1B, two-way ANOVA: F(4, 245) = 1.15, P =
0.35) or on paw edema (Figure 1C, two-way ANOVA: F
(4, 245) = 1.35, P = 0.27). Morphine administered dur-
ing the late phase did not elevate the mechanical
threshold (Figure 1D, two-way ANOVA: F(3, 112) =
0.20, P = 0.89), suggesting that local morphine admin-
istration during the early phase, but not the late phase,
increased the mechanical threshold.
Figure 1 Local administration of morphine in the early, but not the late phase, alleviates hypersensitivity to mechanical stimuli.
Morphine (3 μg or 10 μg) and/or naloxone (5 μg) were injected into the incisional sites during the early phase (1 h after incision and on PODs 1
and 2) or late phase (PODs 5, 6, and 7). The withdrawal threshold to mechanical stimuli (A), withdrawal latency to thermal stimuli (B), and paw
edema (C) were examined in groups, receiving morphine in the early phase. The withdrawal threshold to mechanical stimuli was not altered
by morphine administered in the late phase (D). *P< 0.001, Mor 10 μg compared with Veh, **P< 0.001, Mor 10 μg compared with Mor 3 μg, ***P< 0.0001,
Mor 10 μg compared with (Mor 10 μg + Nal 5 μg), #P < 0.001, Mor 10 μg compared with Nal 5 μg (two-way ANOVA followed by Bonferroni
post-hoc testing). Data are mean ± SEM (Figure 1A-C, n = 8 for each group, Figure 1D, n = 5 for each group). Veh; vehicle, Mor; morphine,
Nal; naloxone.
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hyperalgesia are mediated by local macrophages
We next examined whether morphine exerted its anal-
gesic effects via infiltrated macrophages. To deplete local
macrophages accumulated at the incised sites, clodro-
nate liposomes were directly injected an hour after inci-
sion and on PODs 1 and 2. Macrophage depletion was
evaluated by immunostaining cells with pan-macrophage
marker, F4/80+ and 4′,6-diamidino-2-phenylindole (DAPI)
on POD2 (Figure 2A). The number of F4/80+ cells was
decreased following intraplantar injection of clodronate
liposomes in both vehicle- and morphine-treated paws
(Figure 2B, one-way ANOVA: F(3, 23) = 72.60, P < 0.0001)
although macrophage depletion alone did not change the
sensitivity to mechanical stimuli (Figure 2C). However, theanalgesic effects of morphine on mechanical stimuli were
reversed by depletion of infiltrated macrophages (two-way
ANOVA: F(3, 196) = 18.82, P < 0.0001). The numbers of
F4/80+ cells in empty control-injected paws were not al-
tered by morphine. Therefore, macrophages with a specific
phenotype increased by the administration of morphine but
not by vehicle in the early phase, may contribute to the an-
algesic effects of morphine. Taken together with the results
that morphine administered in the late phase had little ef-
fect on the mechanical threshold (Figure 1D), this suggests
that morphine likely acts on macrophages accumulating in
the early phase. Macrophages are recruited and activated at
local sites within 48 hours after the initiation of inflamma-
tion [20,21]. During the course of pain development, proin-
flammatory M1 macrophages accumulate immediately,
Figure 2 Depletion of local macrophages resulted in decreased analgesic effects of morphine. (A) Macrophage depletion after intraplantar
injection of 10 μL clodronate liposomes was evaluated by immunostaining for local F4/80+ macrophages. Green: F4/80; blue: DAPI. Scale bar:
50 μm. (B) The number of F4/80+ macrophages was reduced by clodronate liposomes. *P < 0.01 (two-way ANOVA followed by Bonferroni post-
hoc testing). Data are mean ± SEM (n = 6 for each group). (C) The elevated withdrawal threshold to mechanical stimuli induced by morphine
was reversed by clodronate liposomes. *P < 0.05, Empty-Mor compared with Empty-Veh, **P < 0.05, Empty-Mor compared with Clodronate-Veh,
***P < 0.05, Empty-Mor compared with Clodronate-Mor (two-way ANOVA followed by Bonferroni post-hoc testing). Data are mean ± SEM (n = 8
for each group). Empty-Veh; empty liposomes 10 μL + vehicle (PBS), Clodronate-Veh; clodronate liposomes10μL + vehicle (PBS), Empty-Mor;
empty liposomes 10 μL + morphine 10 μg, Clodronate-Mor; clodronate liposomes 10 μL + morphine 10 μg.
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phages in the late phase [5,6]. Therefore, we hypothesized
that morphine can attenuate postincisional pain by regulat-
ing phenotype switching of macrophages in the early phase.
Morphine alters macrophage polarity in incision-induced
local inflammation
To determine the macrophage phenotype at morphine-
injected incised sites, numbers of macrophages were
counted by immunostaining with F4/80, DAPI and
either iNOS, an M1-specific marker (Figure 3A), or
CD206, an M2-specific marker (Figure 3B). Consistent
with a previous report showing morphine inhibited the
induction of NOS in macrophage cell line [22], the
number of F4/80+iNOS+ M1 macrophages was signifi-
cantly decreased by administration of morphine com-
pared with vehicle, and this effect was reversed bycoadministration of naloxone on both PODs 2 and 7
(Figure 3C, two-way ANOVA, F (2, 30) = 22.65, P <
0.0001). Differences in the total number of F4/80+
macrophages were not statistically significant. Consist-
ent with decreased numbers of M1 macrophages, the
number of F4/80+CD206+ M2 macrophages was mark-
edly increased by morphine compared with vehicle or
coadministration of naloxone on POD2 (Figure 3C,
two-way ANOVA, F(2, 30) = 5.74, P = 0.008) though
this difference was not apparent on POD7.
To assess further the effects of morphine on the incision-
induced inflammation, we evaluated gene expression of
pro-nociceptive cytokines, IL-1β and TNF-α. Consistent
with a decrease in iNOS+ M1 macrophages at morphine-
treated incisional sites, IL-1β mRNA (Il1β) was markedly
decreased at morphine-treated sites on POD7 (Figure 4,
two-way ANOVA, F(2, 42) = 5.73, P = 0.006). However,
Figure 3 Morphine induces phenotype shifts of local macrophages. The infiltration of F4/80+iNOS+ M1 macrophages (A) and F4/80+CD206+
M2 macrophages (B) was evaluated on PODs 2 and 7. (C) The numbers of total F4/80, F4/80+iNOS+, and F4/80+CD206+ macrophages were
counted. Scale bar, 25 μm. *P < 0.05 (two-way ANOVA followed by Bonferroni post-hoc testing). Each column represents mean ± SEM (n = 6 for
each group). Veh; vehicle (PBS), Mor; morphine 10 μg, Nal; naloxone 5 μg.
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nificant (Figure 4, two-way ANOVA, F(2, 42) = 1.30, P =
0.28). We previously reported that an endogenous opioid,
enkephalin, but not β-endorphin or dynorphin produced by
M2 macrophages might attenuate CFA-induced inflamma-
tory pain [6]. To investigate whether the analgesic effects of
morphine were due to increased production of enkephalin,gene expression of proenkephalin (Penk) was measured.
The expression levels of Penk were 2.5-fold higher in
morphine-treated sites compared with vehicle-treated
sites on POD7 (Figure 4, two-way ANOVA, F(2, 42) = 4.12,
P = 0.023). These data suggest that the macrophage-
mediated analgesic effects by morphine might be due to
the morphine-induced decrease of the pro-nociceptive
Figure 4 Morphine decreases the expression of pro-nociceptive cytokine, IL-1β and increased the expression of endogenous opioid,
enkephalin. The expression levels of Penk were increased at morphine-treated sites. The expression levels of Il1b were reduced at morphine-treated sites,
whereas morphine did not alter the expression levels of Tnf. *P < 0.05, **P < 0.01 (two-way ANOVA followed by Bonferroni post-hoc testing).
Data are mean ± SEM (n = 8 for each group). Veh; vehicle (PBS), Mor; morphine 10 μg, Nal; naloxone 5 μg, Penk; preproenkephalin, Tnf; tumor
necrosis factor, Il1b; interleukin-1β.
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phenotype shift of macrophages in the early phase.
Morphine attenuates mechanical hyperalgesia by acting
downstream of HO-1
Induction of HO-1 promoted a shift in phenotype to M2
macrophages and the wound healing process [23]. We
previously demonstrated that HO-1 was dominantly
expressed by infiltrated macrophages in the early phase
of CFA-induced inflammation [6]. Because morphine-
induced apoptosis of macrophages is inhibited by HO-
1 inhibitors, and HO-1 inducers enhanced the effects
of μ-opioid receptors during neuropathic pain [24], weFigure 5 HO-1 inhibitor SnPP reverses the attenuation of mechanical
mechanical stimuli was examined. *P < 0.001, (DMSO +Mor) compared with
PBS), ***P < 0.001, (DMSO +Mor) compared with (DMSO +Mor) (two-way A
(n = 7 for each group). (B) Morphine did not alter expression levels of Hmo
morphine 10 μg, SnPP; tin protoporphyrin 400 nmol.examined the involvement of HO-1 in morphine-
induced analgesia and the phenotypic shift of macro-
phages. An HO-1 inhibitor, tin protoporphyrin (SnPP),
was coadministered with 10 μg of morphine 1 hour
after the procedure and on PODs 1 and 2. Consistent
with previous reports, intraplantar injection of SnPP
with morphine significantly decreased the mechanical
threshold compared with a single injection of mor-
phine (Figure 5A, two-way ANOVA: F (3, 168) = 30.67,
P < 0.0001). Plantar incision induced a 3.4-fold increase in
HO-1 mRNA (Hmox-1) expression in vehicle-treated
hind-paws 6 hours after incision compared with intact
hind-paws. However, morphine did not change thehyperalgesia by morphine. (A) The withdrawal threshold to
(DMSO + PBS), **P < 0.001, (DMSO +Mor) compared with (SnPP +
NOVA followed by Bonferroni post hoc testing). Data are mean ± SEM
x-1. *P < 0.05. Each bar represents mean ± SEM (n = 6 for each) Mor;
Godai et al. Molecular Pain 2014, 10:36 Page 7 of 13
http://www.molecularpain.com/content/10/1/36expression level of Hmox-1 compared with vehicle controls
or morphine coadministered with naloxone (Figure 5B,
two-way ANOVA: F (2, 30) = 1.10, P = 0.34). In addition,
SnPP reversed the decrease in M1 macrophages and the in-
crease in M2 macrophages induced by morphine (Figure 6,
F4/80+iNOS+ M1 macrophages, two-way ANOVA: F (2,Figure 6 HO-1 inhibitor SnPP blocks morphine-induced phenotype
macrophages (A) and F4/80+CD206+ M2 macrophages (B) were evaluat
and F4/80+CD206+ macrophages were counted. Scale bar, 25 μm. *P< 0.001 (tw
represents mean ± SEM (n = 6 for each group). Veh; vehicle (PBS +DMSO), Mor;30) = 40.53, P < 0.0001, F4/80+CD206+ M2 macrophages,
two-way ANOVA: F (2, 30) = 17.90, P < 0.0001). These
data suggest that HO-1 is essential for morphine-
induced analgesic effects and phenotype switch of
macrophages. However, since HO-1 expression was
not altered by morphine, it is likely that μ-opioidshift of local macrophages. The infiltration of F4/80+iNOS+ M1
ed on PODs 2 and 7. (C) The numbers of total F4/80, F4/80+iNOS+,
o-way ANOVA followed by Bonferroni post-hoc testing). Each column
morphine 10 μg, SnPP; tin protoporphyrin 400 nmol.
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HO-1 induction itself is independent of μ-opioid re-
ceptor signaling in macrophages.
Analgesic effects of morphine on mechanical stimuli was
reversed by COX inhibitor
Prostaglandin E2 (PGE2), a key mediator during acute
inflammation, contributed to hyperalgesia by promoting
sensory neuron hyperexcitability [25]. The majority of
PGE2 synthesis upon initiation of the inflammatory re-
sponse is mediated by a COX-2-dependent pathway in
macrophages, whereas COX-1 is constitutively expressed
in nearly all cell types for house-keeping functions. It
was reported that morphine directly enhanced the re-
lease of arachidonic acid and its metabolites in murine
peritoneal macrophages [26]. The release of PGE2 was
increased from peritoneal macrophages isolated from
rats after receiving morphine for 4 days [27]. To examine
the involvement of COX-2 in morphine-induced analgesia
in post-incisional pain development, the nonselective COX
inhibitor indomethacin was locally administered with mor-
phine 1 hour after the procedure and on PODs 1 and 2.
Indomethacin administered with morphine in the early
phase decreased the mechanical threshold compared with a
single injection of morphine after POD7 (Figure 7A,
two-way ANOVA: F(3, 196) = 24.23, P < 0.0001). Plantar
incision induced a 5.1-fold increase in the expression
of COX-2 mRNA, prostaglandin-endoperoxide synthase
(Ptgs)2 in vehicle-treated hindpaws on POD2 compared
with intact hindpaws (Figure 7B, two-way ANOVA: F(2,
41) = 3.30, P < 0.05). Consistent with a previous report
that morphine increased PGE2 release from macrophages
[27], morphine markedly increased the expression of Ptgs2,Figure 7 COX inhibitor, indomethacin reverses morphine-induced ele
mechanical stimuli was examined. *P < 0.05, (Mor + TB) compared with (PBS
(Mor + TB) compared with (Mor + Indo) (two-way ANOVA followed by Bonf
(B) Morphine increased the expression of Ptgs2 at the incised sites. *P < 0.0
bar represents mean ± SEM (n = 6–9 for each group). TB; tris buffer, Mor; m
naloxone 5 μg.with the maximum level occurring on POD2 (19.1 fold),
which was reversed by naloxone. Therefore, morphine may
attenuate post-incisional hyperalgesia by regulating COX-2/
PGE2-dependent mechanisms in macrophages.
Morphine alters the phenotype of local macrophages
through COX-2-dependent mechanism
COX-2 inhibition by celecoxib promoted a phenotype
shift of tumor-associated macrophages from M2 to M1
in a mouse model of colon cancer [28]. To evaluate the
effects of COX-2 on macrophage polarization over the
time course of the post-incisional process, the M1/M2
balance of macrophages at the incisional sites was evalu-
ated by immunostaining with F4/80, DAPI and M1- and
M2-specific markers, iNOS and CD206, respectively
(Figure 8A and B). Coadministration of indomethacin
blocked the reduction of F4/80+iNOS+ M1 macrophages
induced by morphine on PODs 2 and 7 (Figure 8C, two-
way ANOVA: F (2, 27) = 37.84, P < 0.0001), and reversed
the increase in numbers of F4/80+CD206+ M2 macro-
phages on POD2 (Figure 8C, two-way ANOVA: F (2,
27) = 7.98, P = 0.002). Taken together with data showing
indomethacin reversed morphine-induced analgesia
(Figure 7A), local administration of morphine amelio-
rates mechanical hypersensitivity by altering the M1/M2
balance of macrophages via COX-2-dependent pathway.
We demonstrated that local administration of morphine
in the early phase attenuated post-incisional mechanical
hyperalgesia with a concomitant decrease in M1 macro-
phages and an increase in M2 macrophages. Depletion of
macrophages, inhibition of HO-1 or COX all resulted in
the reversal of morphine-induced analgesia, with an alter-
ation in macrophage phenotype.vation of mechanical threshold. (A) The withdrawal threshold to
+ TB), **P < 0.05, (Mor + TB) compared with (PBS + Indo), ***P < 0.01,
erroni post-hoc testing). Data are mean ± SEM (n = 8 for each group).
5 (two-way ANOVA followed by Bonferroni post-hoc testing). Each
orphine 10 μg, Indo; indomethacin 50 μg, Veh; vehicle (PBS), Nal;
Figure 8 Indomethacin reverses morphine-induced phenotype switch of macrophages. Infiltration of F4/80+iNOS+ M1 macrophages (A)
and F4/80+CD206+ M2 macrophages (B) were evaluated on PODs 2 and 7. (C) The numbers of total F4/80, F4/80+iNOS+, and F4/80+CD206+
macrophages were counted. Scale bar, 25 μm. *P < 0.05, **P < 0.01 (two-way ANOVA followed by Bonferroni post-hoc testing). Each column
represents mean ± SEM (n = 6 for each group). Veh; vehicle (PBS + TB), Mor; morphine 10 μg, Indo; indomethacin 50 μg.
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macrophages preceded that of M2 macrophages during
the course of pain development, resulting in the late
onset of M2 macrophage-derived analgesic effects [5,6].
Although the phenotype shift of macrophages was ob-
served on POD2 (Figure 3), morphine had no analgesic
effects during PODs 1–5 (Figure 1A). This might beexplained by the changes in the expression levels of IL-
1β and enkephalin on POD7, but not POD2 (Figure 4).
These data suggest that functional changes in macro-
phages require additional time after phenotype shift by
the administration of morphine, which may also explain
why levels of enkephalin were increased on POD7 (Figure 5)
although the number of M2 macrophages was unchanged
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that the transient increase in pronociceptive PGE2 by mor-
phine on POD2 (Figure 7B) may have resulted in a small
analgesic effect in the early phase. Wolf et.al. reported that
IL-1β-deficient mice exhibited complete abolishment of
post-incisional pain behavior [27]. Intraplantar injection of
small doses (0.1-100 pg) of IL-1β decreased the mechanical
threshold [29]. Taken together with our data, IL-1β might
be the critical mediator for the development of mechanical
hyperalgesia, partly regulated by μ opioid receptor signaling
(Figure 4).
Although it has been reported that a single adminis-
tration of morphine into the hindpaw attenuated paw
edema and thermal hyperalgesia in the acute phase of a
carrageenan-induced inflammatory pain model [30],
intraplantar morphine had no effect on paw edema
when carrageenan was repeatedly administered [10].
Supporting these previous reports, in the present study
peripherally administered morphine had no effect on
paw edema or hyperalgesia to heat stimuli from 1 day
after incision (Figure 1). We previously reported that a
phenotype shift to M2 macrophages by PPARγ signaling al-
tered the threshold to mechanical, but not thermal stimuli
in a CFA-induced inflammatory pain model [6]. Thus, the
development of thermal hyperalgesia may be modulated by
macrophage-independent mechanisms.
In the present study, morphine was repeatedly adminis-
tered for 3 days (days 0–2 or 5–7) after incision. Therefore,
peripheral morphine tolerance is a concern for this study.
Although the analgesic response was eliminated in mice re-
ceiving topical morphine alone for 3 days [31], Zollner et al.
reported that mice receiving chronic morphine treatment
(10 mg/kg subcutaneously twice daily for 4 days) did not
develop tolerance at the peripheral μ-opioid receptors
in the presence of CFA-induced paw inflammation [32].
Furthermore, they demonstrated that tolerance ensued
when endogenous opioid peptides in inflamed tissue were
removed by antibodies or by depleting opioid-producing
leukocytes with cyclophosphamide. Because the majority of
opioid-containing leukocytes were ED1+ monocytes/macro-
phages in the late stage of CFA–induced inflammation [21],
the possibility that the phenotype of local macrophages
might have played a role in peripheral opioid tolerance
during the development of inflammatory pain could not be
excluded. Further investigation is needed to clarify the in-
volvement of macrophage polarization in opioid tolerance.
The expression of COX-2 was increased in the early
phase by morphine administration, and the analgesic
effects of morphine in the late phase were reversed by
coadministration of indomethacin (Figure 7). The pheno-
typic shift of local macrophages by morphine was mediated
by COX-dependent mechanism (Figure 8). COX-2/PGE2 is
known to be a pronociceptive mediator mainly released by
local macrophages during acute inflammation. In responseto peripheral inflammatory challenges by the administration
of carrageenan and CFA, mice lacking the ATP-gated P2X4
channel did not elicit pain hypersensitivity and lacked the
COX-dependent release of PGE2 [25], suggesting that
COX-dependent release of PGE2 from macrophages is
essential for the development of inflammatory pain.
Conversely, previous reports have demonstrated that
PGE2 promoted the differentiation of macrophages to
the anti-inflammatory M2 phenotype [33,34]. PGE2 re-
lease was enhanced from peritoneal macrophages iso-
lated from morphine-dependent rats [27]. Although
the expression levels of Ptgs2 were not different be-
tween vehicle- and morphine-injected sites on POD7,
morphine-injected mice exhibited less hypersensitivity
to mechanical stimuli in the late phase. Therefore, we
speculate that peripheral COX-2 in the microenviron-
ment might have pronociceptive effects in the early
phase, but inhibit the development of chronic pain by
altering macrophage phenotype in the late phase.
We previously reported that HO-1 induced macro-
phage polarity towards the M2 phenotype [6,9]. Despite
our results showing HO-1 mRNA levels were unchanged
by morphine treatment, the HO-1 inhibitor SnPP effect-
ively reversed the effects of morphine on mechanical
threshold and macrophage polarity (Figures 5 and 6).
Hervera et al. reported that an HO-1 inducer, cobalt
protoporphyrin IX increased μ opioid receptor protein
levels in the ipsilateral dorsal root ganglia in a mouse
model of neuropathic pain model [24], suggesting that μ
opioid receptors might be downstream of the HO-1 sig-
naling pathway. Because morphine increased the expres-
sion of PGE2, and the analgesic effects of μ opioid
receptor were inhibited by a COX-2 inhibitor, indometh-
acin, the analgesic effects of μ opioid receptor signaling
might be dependent on COX-2/PGE2 (Figure 9).
Conclusions
We demonstrated that local administration of morphine at-
tenuates the development of postincisional hyperalgesia
through macrophage-dependent mechanisms. Phenotype
shifts of local macrophages were induced by morphine
administered early in the course of pain development, pos-
sibly through a COX2/PGE2-dependent pathway. There-
fore, peripheral μ opioid receptors in macrophages could
be a potential new therapeutic target for the development
of postoperative pain therapies.
Methods
Animals
Male C57BL6 mice aged 8–10 weeks were obtained from
CLEA Japan, Inc. (Tokyo, Japan). The Animal Research
Committee of Kagoshima University approved all experi-
mental procedures, which were implemented according
to the guidelines of the National Institutes of Health and
Figure 9 Schematic diagram of morphine-induced analgesia
representing the molecular pathways in macrophages.
Peripherally administered morphine alters macrophage polarity
through a COX2/PGE2-dependent pathway. Morphine-induced
changes in macrophage polarity decrease IL-1β levels, and increase
PGE2 and enkephalin in the late phase. HO-1 might be upstream of
μ opioid receptor signaling.
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Mice were housed in groups of four or five per cage in a
12 hour light–dark cycle.
Paw incision model
The mouse hindpaw plantar incision model was created as
described previously [36]. Mice were deeply anesthetized by
inhalation of 1.5–2.0% isoflurane (Abbott, Tokyo, Japan) via
a nose cone. A 5-mm longitudinal incision was made with
a No. 11 blade through the skin and fascia of the plantar
foot. The incision was started 2 mm from the proximal
edge of the heel and extended toward the toes. The under-
lying muscle was elevated with a curved forceps leaving the
muscle origin and insertion intact. The skin was apposed
with a single mattress suture of 8–0 nylon. Morphine
(Shionogi & Co. LTD., Japan) was dissolved in phosphate-
buffered saline (PBS, pH 7.2), SnPP (Tocris Bioscience,
Bristol, UK) was diluted in dimethyl sulfoxide (DMSO),
and indomethacin (Nacalai Tesque, Kyoto, Japan) was di-
luted in Tris buffer (TB, pH8.0). Morphine (3 μg/20 μL or
10 μg/20 μL), naloxone (5 μg/20 μL, Wako, Osaka, Japan),
SnPP (400 nmol/20 μL) or indomethacin (50 μg/20 μL)
were injected locally to the incisional sites 1 hour after the
skin was sutured, and on PODs 1 and 2, or on PODs 5–7.
The total amount of solution injected to the hind paws was
20 μL/paw for all experiments. The suture was removed at
the end of POD2.
Pain behavior
All behavioral experiments were performed by the same
tester in a blinded manner. Withdrawal latencies to heatstimuli were assessed by applying a focused radiant heat
source to an unrestrained mouse placed on a heat-
tempered glass floor using the Paw Thermal Stimulator
(UCSD, San Diego, CA, USA). A thermal stimulus was
then applied to the plantar surface of each hind paw.
Each mouse was tested at an interval of 2–3 minutes.
The latencies to thermal stimuli were calculated as the
mean of three trials. A cut-off time was set at 20.5 s to
avoid tissue damage. To evaluate tactile allodynia, cali-
brated von Frey filaments (0.08–2.00 g) were applied to
the plantar surface of the hindpaw from underneath
the mesh floor. The 50% paw withdrawal threshold was
determined using the updown method [37]. Behavioral
experiments were performed before the administration
of reagents to hind paws on PODs 1, 2, 5, 7, 10, 12,
and 14.
Measurement of paw edema
Post-incisional edema, reflected by an increase in dorsal-to-
ventral paw thickness, was measured by a micro-caliper
(Shinwa Measuring Tools; Niigata, Japan). The mean
of three measurements at each time-point was used for
analysis.
Depletion of local macrophages
For macrophage depletion, 10 μL of clodronate encapsu-
lated in liposomes (Clophosome-A) or empty control
liposomes (Formu Max, Palo Alto, CA, USA) were lo-
cally injected into the incisional sites 1 hour after the
skin was sutured, and on PODs 1 and 2.
Immunohistochemistry
Mice were deeply anesthetized with sodium pentobarbital
(50 mg/kg intraperitoneally) and transcardially perfused
with saline. Tissues were fixed in 4% paraformaldehyde
overnight at 4°C and placed in 30% sucrose solution for
24 h at 4°C. Sections (30 μm thick) were incubated over-
night with primary antibodies to pan-macrophage marker,
F4/80 (1:100; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), iNOS (1:500; Abcam, Cambridge, UK), or CD206
(1:100; Santa Cruz Biotechnology) at 4°C overnight and
then incubated for 1 hour at room temperature with Alexa
Fluor 488- or Alexa Fluor 546-conjugated secondary anti-
body (1:500; Invitrogen, Carlsbad, CA, USA) followed
by nuclear staining with DAPI (Vector Laboratories,
Burlingame, CA, USA). Fluorescent images were obtained
using an LSM700 imaging system (Carl Zeiss, Aalen,
Germany). The intensity of F4/80 immunofluorescence at
clodronate-treated sites, the number of total F4/80+, F4/
80+iNOS+, or F4/80+CD206+ cells with clearly visible
nuclei stained by DAPI were evaluated using Image
J 1.43u 2010 software (National Institutes of Health,
Bethesda, MD, USA).
Godai et al. Molecular Pain 2014, 10:36 Page 12 of 13
http://www.molecularpain.com/content/10/1/36Quantitative PCR
Total RNA of hind paws was extracted from the hindpaw
using Sepazol reagent (Nacalai Tesque, Kyoto, Japan). The
synthesis of first-strand cDNA was performed using High
Capacity RNA-to-cDNA (Applied Biosystems, Carlsbad,
CA, USA) according to the manufacturer’s instructions.
Quantitative PCR was performed on an ABI Prism
StepOnePlus real-time PCR System (Applied Biosystems)
TaqMan assays were performed for quantification of Il-1β
(assay ID:Mm00434228_m1), Tnf (assay ID:Mm004432
60_g1), Penk (assay ID:Mm012128758_m1), and Hmox-1
(assay ID:Mm00516005_m1) using TaqMan Fast Advanced
Master Mix (Applied Biosystems) according to the manu-
facturer’s instructions. Target gene expression was normal-
ized to glyceraldehyde 3-phosphate dehydrogenase.
Statistical analysis
Data are presented as mean ± SEM. Differences among
groups were analyzed using one-way or two-way ANOVA
followed by Bonferroni post hoc testing (Graphpad Prism
5.0, La Jolla, CA, USA). A value of P < 0.05 was considered
significant.
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